PDCD4 and cancer: Moreover, the authors suggested that miR-744-3p enhances the pro-metastatic ability of laryngeal cancer cells through programmed cell death 4 (PDCD4) and PTEN targeting, leading to the activation of matrix metallopeptidase 9 (MMP-9), which enables cancer cell migration [83].